Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
58.76 EUR | +2.33% | +4.63% | -0.37% |
11:09am | CAC40: all-time high, tackles 8250 resistance level | CF |
Mar. 11 | European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise | MT |
Sales 2024 * | 7.04B 7.58B | Sales 2025 * | 7.56B 8.14B | Capitalization | 11.04B 11.89B |
---|---|---|---|---|---|
Net income 2024 * | 418M 450M | Net income 2025 * | 565M 609M | EV / Sales 2024 * | 2 x |
Net Debt 2024 * | 3.07B 3.31B | Net Debt 2025 * | 3.02B 3.26B | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
25.3
x | P/E ratio 2025 * |
19.2
x | Employees | 61,798 |
Yield 2024 * |
1.43% | Yield 2025 * |
1.6% | Free-Float | 66.87% |
Latest transcript on Eurofins Scientific SE
1 day | +0.94% | ||
1 week | +3.21% | ||
Current month | +4.92% | ||
1 month | +6.70% | ||
3 months | -2.03% | ||
6 months | +9.28% | ||
Current year | -1.73% |
Managers | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 14-12-31 |
Christian Wurst
COO | Chief Operating Officer | - | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 86-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 91-12-31 |
Valérie Hanote
BRD | Director/Board Member | 58 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 18 M€ | +7.01% | - | |
0.40% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 58.76 | +2.33% | 183 222 |
24-03-27 | 57.42 | +0.98% | 294,459 |
24-03-26 | 56.86 | +1.68% | 280,989 |
24-03-25 | 55.92 | -0.07% | 494,429 |
24-03-22 | 55.96 | -0.36% | 208,278 |
Real-time Euronext Paris, March 28, 2024 at 06:18 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.73% | 11.94B | |
+0.60% | 99.96B | |
+22.54% | 87.73B | |
+10.63% | 29.33B | |
-4.72% | 18.21B | |
-4.95% | 14.51B | |
+19.29% | 12.22B | |
+30.63% | 12B | |
-31.93% | 11.56B | |
-10.67% | 11.63B |